Mable is a personalized migraine clinic using DNA to find and provide the right medication alongside continuous expert care Using our approach, patients have an 80% higher treatment satisfaction rate, have one extra day per week to enjoy their life and get 55% pain reduction.
Roman is a neuroscientist who has conducted several years of research on memory encoding in the brain, neuropharmacology and drug target characterization. During his PhD at Oxford University he uncovered a new mechanism causing brain-wide synchronization which is necessary for correct retrieval of complex memories. He also has an MSc in Neuroscience (Oxford, UK) and MSc in Biology (Tubingen, Germany).
Inna is Co-Founder and COO of Neurolytic Healthcare Inc (dba Mable). Prior to this, Inna completed her PhD in Health Economics, where she used large healthcare datasets to investigate treatment gaps in chronic disease management. She has consulting expertise in market access, reimbursement and regulatory approval strategy for medical devices.